| |
|
|
Il Sung Pharm. (003120) |
|
|
STOCK |
|
|
|
  |
(unit : Won, Share) |
| Fiscal Year End |
05.12 | 06.12 | 07.12 | 08.03 |
| Par Value |
5,000 | 5,000 | 5,000 | 5,000 |
| Yearly Highest Price |
65,700 | 85,900 | 141,000 | 118,500 |
| Yearly Lowest Price |
20,500 | 48,000 | 77,700 | 74,500 |
| Common Shares O/S |
2,660,000 | 2,660,000 | 2,660,000 | 2,660,000 |
| Preferred Shares O/S |
- | - | - | - |
| Market Cap.(100Mn.Won) |
1,303 | 2,258 | 2,992 | 2,660 |
| Dividends (%) |
8.0 | 10.0 | 10.0 | - |
|
 |
(Company/Sector/Market) |
| |
2006.12 | 2007.12 |
| Beta |
0.41 / 0.92 / 1.00 | 0.52 / 0.75 / 1.00 |
| Volatility |
31.04 / 24.64 / 18.09 | 37.75 / 24.30 / 22.80 |
|
 |
(unit : Won) |
| Fiscal Year End |
05.12 | 06.12 | 07.12 | 08.03 |
| Earnings Per Share |
10,586 | 14,485 | 6,700 | 9,912 |
| Sales Per Share |
29,014 | 29,545 | 29,841 | 32,143 |
| Book Value Per Share |
66,013 | 86,563 | 150,375 | 147,844 |
| Cash Flow Per Share |
6,684.92 | 4,470.45 | 1,579.05 | 8,891.68 |
|
 |
(Unit : Times) |
| Fiscal Year End |
05.12 | 06.12 | 07.12 | 08.03 |
| Price / Earnings (H/L) |
6.21/1.94 | 5.93/3.31 | 21.04/11.60 | 11.96/7.52 |
| Price / Sales (H/L) |
2.26/0.71 | 2.91/1.62 | 4.72/2.60 | 3.69/2.32 |
| Price / Book (H/L) |
1.00/0.31 | 0.99/0.55 | 0.94/0.52 | 0.80/0.50 |
| Price / Cash Flow (H/L) |
9.83 / 3.07 | 19.22 / 10.74 | 89.29 / 49.21 | 13.33 / 8.38 |
|
 |
(Unit : 100Mn.Won, %) |
| Fiscal Year End |
04.12 |
05.12 |
06.12 |
07.12 |
| Company |
Sector |
Company |
Sector |
Company |
Sector |
Company |
Sector |
| Invested Capital |
535 |
501 |
450 |
480 |
524 |
524 |
572 |
544 |
| NOPLAT |
113 |
38 |
142 |
36 |
151 |
35 |
145 |
47 |
| Return on Invested Capital |
21 |
9 |
31 |
9 |
28 |
7 |
25 |
9 |
| WACC |
6 |
5 |
6 |
6 |
5 |
7 |
6 |
6 |
| Economic Value Added |
80.7 |
10.6 |
110.8 |
7.3 |
121.0 |
3.9 |
110.5 |
11.8 |
|
 |
(Unit : 100Mn.Won, Times) |
| Fiscal Year End |
2005.12 | 2006.12 | 2007.12 | 2008.03 |
| Enterprise Value(EV) |
1,303.40 | 2,258.34 | 2,992.50 | 2,660.00 |
| EBITDA |
217.99 | 228.56 | 219.46 | 258.58 |
| EBITDA/Sales |
0.28 | 0.29 | 0.28 | 0.31 |
| EBITDA/Financial Exp. |
6,957.88 | 622.13 | 659.92 | 60.83 |
| EV/EBITDA |
5.98 | 9.88 | 13.64 | 10.29 |
|
|
|
|
